academic article

• Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010..  International journal of MS care.  14:105-114. 2012
• A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients..  Multiple sclerosis (Houndmills, Basingstoke, England).  12:309-320. 2006
• Glatiramer acetate therapy for multiple sclerosis: a review..  Expert opinion on drug metabolism & toxicology.  2:1019-1029. 2006
• Neurologic consequence of delaying glatiramer acetate therapy for multiple sclerosis: 8-year data..  Acta neurologica Scandinavica.  111:42-47. 2005
• Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial..  Multiple sclerosis (Houndmills, Basingstoke, England).  9:585-591. 2003